These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14266590)

  • 21. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHEMICAL THERAPY OF WILSON'S DISEASE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB
    J Indian Med Prof; 1965 Jul; 12():5399-402. PubMed ID: 14339732
    [No Abstract]   [Full Text] [Related]  

  • 23. D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
    SCHEINBERG IH
    J Chronic Dis; 1964 Apr; 17():293-8. PubMed ID: 14141837
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial Wilson's disease: copper induced hemolysis, hypersplenism and hyperpigmentation as the main symptoms].
    Steiner P; Frey P; Lupi GA; Kistler HJ
    Schweiz Med Wochenschr; 1975 Jul; 105(27):872-9. PubMed ID: 1215885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.
    DENNY-BROWN D
    N Engl J Med; 1964 May; 270():1149-56. PubMed ID: 14129061
    [No Abstract]   [Full Text] [Related]  

  • 27. Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a Wilson disease patient with hepatic presentation, anxiety and SPECT abnormalities.
    Leggio L; Ferrulli A; Mirijello A; Abenavoli L; Di Giuda D; Funiciello S; Rotoli M; Gasbarrini G; Addolorato G
    Int J Immunopathol Pharmacol; 2007; 20(1):185-90. PubMed ID: 17346443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FAMILIAL HEPATIC COPPER STORAGE DISEASE: A VARIANT OF WILSON'S DISEASE.
    FISHER MM; SHERLOCK S
    Arch Dis Child; 1964 Feb; 39(203):14-7. PubMed ID: 14160082
    [No Abstract]   [Full Text] [Related]  

  • 29. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WILSON'S DISEASE AS A GASTROENTEROLOGIC PROBLEM.
    STERNLIEB I
    Am J Gastroenterol; 1964 Sep; 42():264-70. PubMed ID: 14202497
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 38. Wilson's disease: the role of penicillamine.
    Carmichael BM
    Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Trans Am Neurol Assoc; 1961; 86():131-4. PubMed ID: 13899919
    [No Abstract]   [Full Text] [Related]  

  • 40. Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
    Kong HL; Yap IL; Kueh YK
    Singapore Med J; 1996 Dec; 37(6):670-2. PubMed ID: 9104075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.